Truist Financial Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Raises Target Price to $180

Futu News11minutes ago · Ratings

RBC Capital Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Raises Target Price to $140

Futu NewsJan 7 22:31 · Ratings

RBC Lifts Price Target on Axsome Therapeutics to $140 From $138, Keeps Outperform Rating

MT NewswiresJan 7 20:53 · Ratings

Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) Profit Outlook

Yahoo FinanceJan 6 21:21

Needham Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $133

Futu NewsJan 6 20:31 · Ratings

Axsome Therapeutics Price Target Maintained With a $133.00/Share by Needham

Dow JonesJan 6 19:36 · Ratings